Investing.com - Entera Bio (NASDAQ: ENTX) reported third quarter EPS of $-0.080, in line with the analyst estimate of $-0.080. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Entera Bio's stock price closed at $0.700. It is up 17.370% in the last 3 months and up 30.170% in the last 12 months.
Entera Bio saw positive EPS revisions and negative EPS revisions in the last 90 days. See Entera Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Entera Bio's Financial Health score is "fair performance".
Check out Entera Bio's recent earnings performance, and Entera Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar